
Test your knowledge of the week's events with NPR's weekly news quiz, featuring Nobel prizes, protests, and more.
AI-generated summary
NPR regularly publishes weekly news quizzes based on current events.
This week: Nobels! Protests! Ambiguous quotes! A mysterious death in Russia! What more could you want from a quiz, besides a perfect score? Oh, just 12 million Swedish kronor, you say? Then win a Nobel Prize.
NPR does not offer or accept money for coverage or interviews.
Anyone who makes such an offer or request is not an NPR employee and does not represent NPR.

The World Health Organization requested more information about the death of an employee at a Russian plague research lab, while Russia stated the woman died of pneumonia of unknown origin and denied any health emergency.

A 28-year-old Russian researcher studying plague in a Siberian lab died of pneumonia of unknown origin, prompting quarantine of 200 contacts and WHO criticism of Russia's incomplete assurances, while experts detail pneumonic plague's dangers and historical quarantine practices.

Eli Lilly and Novo Nordisk are developing amylin-targeting drugs to enhance obesity and Type 2 diabetes treatment. Phase 2 trials for Lilly's eloralintide show increased weight loss when combined with tirzepatide, though researchers note challenges with side effects.

Eli Lilly reported that its experimental combination therapy of eloralintide and tirzepatide achieved up to 23.3% weight loss in a Phase 2 trial for patients with obesity and Type 2 diabetes, outperforming tirzepatide alone. Phase 3 trials are planned for late 2026.

Novo Nordisk presented real-world data showing patients who switched from obesity injections to its new Wegovy pill continued losing weight after three months.

Montana's early rollout of Medicaid work requirements sparks confusion as enrollees receive contradictory notices, raising concerns about potential coverage losses ahead of the national deadline.